Anzeige
Erschienen in:
01.11.2014 | Neuro
1H-MRS is useful to reinforce the suspicion of primary central nervous system lymphoma prior to surgery
Erschienen in: European Radiology | Ausgabe 11/2014
Einloggen, um Zugang zu erhaltenAbstract
Objectives
To assess whether 1H-MRS may be useful to reinforce the radiological suspicion of PCNSL.
Methods
In this retrospective study, we included 546 patients with untreated brain tumours in which single-voxel spectroscopy at TE 30 ms and 136 ms had been performed. The patients were split into two subgroups: “training set” and “test set.” Differences between PCNSL and five other types of intracranial tumours were assessed in the test set of patients using the Mann-Whitney U nonparametric test and cut-off values for pair-wise comparisons defined by constructing receiver operating characteristic curves. These thresholds were used to construct classifiers for binary comparison between PCNSL and non-PCNSL. The performance of the obtained classifiers was assessed in the independent test set of patients.
Results
Significant differences were found between PCNSL and the other groups evaluated. All bilateral comparisons performed in the test set obtained accuracy values above 70 % (71–89 %). Lipids were found to be useful to discriminate between PCNSL and glioblastoma/metastasis at short TE. Myo-inositol resonance was found to be very consistent for discriminating between PCNSL and astrocytomas at short TE.
Conclusions
1H-MRS is useful to reinforce diagnostic suspicion of PCNSL on MRI.
Key Points
•
1
H-MRS can be used to reinforce the diagnostic suspicion of PCNSL.
• Lipids can be used to discriminate between PCNSL and GB/MET.
• Myo-inositol resonance can be used to discriminate between PCNSL and astrocytomas.